Restoration of Thymopoiesis in pTα−/− Mice by Anti-CD3ε Antibody Treatment or with Transgenes Encoding Activated Lck or Tailless pTα  by Fehling, Hans Jörg et al.
Immunity, Vol. 6, 703±714, June, 1997, Copyright 1997 by Cell Press
Restoration of Thymopoiesis in pTa2/2 Mice by
Anti-CD3e Antibody Treatment or with Transgenes
Encoding Activated Lck or Tailless pTa
Hans JoÈ rg Fehling,1 Brian M. Iritani,2,3 Anna Krotkova,1 CD251442/low117low cells proliferate rapidly, down-regu-
late CD25,and differentiate into CD4181 double-positiveKatherine A. Forbush,2,6 Catherine Laplace,1
(DP) thymocytes, which account for z80% of thymicRoger M. Perlmutter,2,4±6 and Harald von Boehmer7
cellularity. Cells that have reached the DP stage support1Basel Institute for Immunology
rearrangements at their TCRa loci, express a matureCH-4005 Basel
ab TCR on the cell surface, and undergo positive andSwitzerland
negative selection. DP thymocytes surviving this pro-2Department of Immunology
cess shut offÐdepending on the specificity of their3Department of Comparative Medicine
TCRÐeither CD4 or CD8 expression and give rise to4Department of Biochemistry
mature single positive (SP) cells with a self-tolerant, self-5Department of Medicine
MHC-restricted TCR repertoire, which then populate the6Howard Hughes Medical Institute
peripheral lymphoid organs (reviewed by Kisielow andUniversity of Washington
von Boehmer, 1995; reviewed by Guidos, 1996).Seattle, Washington 98195±7650
The selective expansion of DN cells with productive7Institut Necker
TCRb rearrangements at the CD251442/low117low stageINSERM 373
has been termed ``b selection'' and is mediated by theF-75730 Paris Cedex 15
pre-TCR, which consistsÐat minimumÐof a conven-France
tional TCRb chain, a monomorphic pre-TCRa (pTa)
chain, and certain components of the CD3 complex,
including CD3e and CD3g (reviewed by von BoehmerSummary
and Fehling, 1997). Only cells that manage to rearrange
one TCRb allele in-frame can synthesize a functionalMice deficient for the pre-TCRa (pTa) chain cannot
TCRb chain and generate a signaling-competent pre-form a pre-T cell receptor (TCR) and exhibit a severe
TCR complex. Expression of the pre-TCR on the celldefect in early T cell development, characterized by
surface alone or its interaction with a ligand on thymiclack of ``b selection'' and impaired generation of dou-
stroma triggers a maturational program that includesble-positive (DP) thymocytes. Here, we demonstrate
intense cellular proliferation, down-regulation of CD25,that intraperitoneal injection of CD3e-specific antibod-
up-regulation of CD4 and CD8, and arrest of furtheries into pTa2/2 3 RAG2/2 mice or introduction of an
rearrangements at the TCRb locus (b allelic exclusion).activated p56lck transgene in pTa2/2 mice fully restores
The net result of this pre-TCR-mediated selection is the
the number of DP thymocytes, and that expression of
generation of an expanded population of DP thymocytes
a transgenic pTa chain lacking its cytoplasmic portion
with a single productive TCRb rearrangement (reviewedcan overcome all developmental defects associated
by Fehling and von Boehmer, 1997).with pTa deficiency. These results allow a better defi-
Mice that cannot produce an essential component of
nition of the role of pTa in pre-TCR signal transduction
the pre-TCR due to targeted disruption of the corre-
and provide conclusive evidence that the cytoplasmic
sponding gene exhibit severe defects in T cell develop-
tail of pTa is not essential for pre-TCR signaling.
ment. For instance, in RAG2/2 mice, which cannot
rearrange their TCR loci, T cell development is com-
pletely arrested at the CD251442/low117low DN stage, and
Introduction DP thymocytes are not detectable (Mombaerts et al.,
1992a; Shinkai et al., 1992; Godfrey et al., 1994). Simi-
Most ab T lymphocytes differentiate and mature within lar, albeit less severe defects are found in TCRb-
the thymus. Successive developmental stages of devel- (Mombaerts et al., 1992b) and pTa-deficient (Fehling
oping thymocytes correlate wellwith the expression pat- et al., 1995a) mice. In both mutants, the transition from
tern of CD4 and CD8 coreceptors (reviewed by Kisielow DN to DP thymocytes and the cellular proliferation asso-
and von Boehmer, 1995). The most immature thymo- ciated with this transition are severely impaired, again
cytes reside in the CD4282 double-negative (DN) popu- at the CD251442/low117low DN stage, which results in a
lation, which comprises only about 1%±2% of all dramatic decrease in the absolute number of DP thymo-
thymocytes and can be further subdivided into at least cytes and a concomitant, .90% reduction in total thy-
four discrete stages, defined by the differential expres- mic cellularity. The few DP thymocytes (about 1%±5%
sion of CD25 (IL-2 receptor a chain), CD44 (Pgp-1), and of normal) that are found in the thymus of these mutants
CD117 (c-kit) (Godfrey et al., 1993, 1994; reviewed by appear to arise by a pre-TCR independent mechanism
Shortman and Wu, 1996). At the CD251442/low117low pre-T (Buer et al., 1997). Since, in the case of pTa-deficient
cell stage, DN thymocytes rearrange their TCRb locus mice, these DP cells can form a mature ab TCR, small
(Godfrey et al., 1994) and become subject to an impor- numbers of apparently normal ab T cells are generated
tant selection event, which allows only those cells to despite the absence of an intact pre-TCR.
expand and progress in their development that succeed Several lines of evidence document the involvement
in generating a functional TCRb chain (Dudley et al., of the lymphocyte-specific tyrosine kinase p56lck in the
1994; reviewed by Levelt and Eichmann, 1995; re- transmission of pre-TCR-mediated signals (reviewed
by Anderson and Perlmutter, 1995). Mice lacking lckviewed by Fehling and von Boehmer, 1997). Selected
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(Molina et al., 1992) or overexpressing a kinase-inactive double-deficient mice (Figure 1, middle panels), which
clearly shows that cell surface expression of signaling-lck transgene (Levin et al., 1993) exhibit a defect in early
T cell development similar to that seen pTa- or competent CD3e chains is possible even in the absence
of the pTa chain.TCRb-deficient mice. Moreover, an lck transgene en-
coding a constitutively active kinase, when introduced As reported previously (Rueff-Juy et al., 1990 and ref-
erences therein) and also found by us (data not shown),into RAG2/2 mice, leads to the generation of large num-
bers of DP thymocytes, indicating that activated lck can treatment of wild-type (WT) mice with CD3e-specific an-
tibodies has a negative effect on thymocyte develop-bypass pre-TCR-mediated signals (Mombaerts et al.,
1994). There isalso abundant evidence that components ment, leading to a reduction in thymocyte number and
essentially complete elimination of DP cells. This wasof the CD3 complex are essential for pre-TCR signal
transduction (reviewed by Malissen and Malissen, 1996; also observed when adult pTa single-deficient mice
were injected with 145±2C11 (Figure 1, lower panels).reviewed by Borst et al., 1996). In fact, pre-TCR signaling
can be bypassed by treating fetal thymic organ cultures The detrimental effect of anti-CD3 antibodies in adult
WT and pTa-deficient mice is probably due to anti-CD3-of TCRb2/2 mice with anti-CD3e-specific antibodies
(Levelt et al., 1993) or by injecting such antibodies into induced activation of mature T cells, which are absent
in RAG2/2 but not inpTa2/2 mutant mice, and concurrentRAG-deficient mice (Shinkai and Alt, 1994; Jacobs et
al., 1994). This treatment leads to strong proliferation of induction of T lymphokines, like TNF, that are known to
be toxic for DP thymocytes (Rueff-Juy et al., 1990).DN thymocytes and generation of essentially normal
numbers of DP cells. The striking effect of CD3e-specific
antibodies on T cell development inRAG2/2 mice implies
A Transgene Encoding Constitutively Activatedthat at least CD3e must be exposed on the cell surface,
p56lck Can Restore Early T Cell Developmentdespite the absence of mature T cell receptor (TCR)
in pTa-Deficient Micechains. CD3e could be associated with a receptor form
Phosphorylation of tyrosine residue 505 in the C-termi-that consists of pTa and a nonrearranging surrogate
nal part of p56lck sterically suppresses its catalytic func-chain for TCRb.
tion; substitution of this residue with phenylalanine cre-In previous work, we described major defects in T
ates a constitutively active form of p56lck (Martin et al.,cell development in pTa-deficient mice (Fehling et al.,
1988). Previous studies have shown that expression of1995a). Here, we address more intricate questions by
this activated mutant form under the control of its ownanalyzing pTa2/2 mice that bear additional genetic modi-
proximal promoter in RAG2/2 mice results in the devel-fications. First, mice were bred to become deficient for
opment of large numbers of DP thymocytes, demon-both RAG-2 and pTa. Double-deficient animals were
strating that activated lck can overcome the arrest intreated with CD3e-specific antibodies to see whether
early ab T cell development that is normally associatedexpression of signaling-competent CD3e on the cell sur-
with RAG deficiency (Mombaerts et al., 1994). To testface of immature DN thymocytes, lacking conventional
whether constitutively active lck can also surmount theTCR chains, depends on the presence of pTa. Second,
defect in T cell development that is observed in pTa-a transgene encoding a constitutively active form of
deficient mice, we crossed mice transgenic for p56lckp56lck was crossed onto a pTa2/2 background in order
(line pLGF-2954) (Abraham et al., 1991) with pTa2/2 miceto test whether this kinase could rescue early T cell
(Fehling et al., 1995a).development despite the lack of pTa. Finally, we evalu-
When the lck transgene was introduced into the pTaated the role of the cytoplasmic tail of pTa in pre-TCR-
mutant background, the number of DP thymocytes wasmediated functions by introducing into pTa2/2 mice a
restored to WT levels. Figure 2 shows the result of atransgenic pTa chain that lacks its cytoplasmic res-
representative analysis. The percentage of DP thymo-idues.
cytes is increased from 35% to 77% and the absolute
number of thymocytes from 4.7 3 106 to 89.6 3 106Results
in pTa2/2 3 lck-TG versus pTa2/2 mice (Figure 2, top
panels). Since activated lck inhibits V-DJb rearrange-The Pre-TCRa Chain Is Not Required for Functional
mentsÐa phenomenon that is thought to reflect allelicCell Surface Expression of CD3e on Pre-T Cells
exclusion at the TCRb locusÐthe percentage of DP thy-Six- to ten-week-old mice derived from an F2 intercross
mocytes with surface expression of TCRb is significantlybetween RAG-22/2 (Shinkai et al., 1992) and pTa2/2 mice
reduced in mice expressing an activated lck transgene(Fehling et al., 1995a)were injected intraperitoneally with
(Anderson et al., 1992). Our analysis confirmed this ear-30 mg of the affinity-purified anti-CD3e-specific mono-
lier observation and revealed a similar effect on DP thy-clonal antibody 145±2C11 (Leo et al., 1987). Six days
mocytes that develop in lck-transgenic mice in the ab-later, thymocytes were prepared, counted, and stained
sence of pTa (Figure 2, bottom panels).for CD4 and CD8 expression. As had been shown pre-
We also analyzed the CD44/CD25 profile of DN thymo-viously by others (Shinkai and Alt, 1994; Jacobs et al.,
cytes in lck-transgenic, pTa2/2 mice. To this end, we1994), treatment of RAG2/2 mice with anti-CD3e-specific
complement depleted CD4- and CD8-positive thymo-monoclonal antibodies resulted in the efficient genera-
cytes and gated on cells that are negative for CD3, CD4,tion of DP thymocytes and an approximately 20- to 50-
CD8, B cell- (CD19), granulocyte- (GR1), and macro-fold increase in total thymocyte number (Figure 1, top
phage-specific (CD11c) markers (for details see Experi-panels). Interestingly, exactly the same result was ob-
tained when 2C11 was injected into RAG2/2 3 pTa2/2 mental Procedures and Figure 3). In pTa-deficient mice,
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Figure 1. Efficient Induction of CD41CD81
Thymocytes in RAG2/2 3 pTa2/2 Double-
Deficient Mice by Intraperitoneal Injection of
Anti-CD3e Antibodies
Six- to ten-week old mice deficient for RAG-2
(top), pTa (bottom), or both (middle) were in-
jected intraperitoneally with 200 ml PBS con-
taining 30 mg of the affinity-purified CD3e-
specific antibody 145±2C11 (Leo et al., 1987)
(a kind gift of Ed Palmer, Basel). Control ani-
mals were injected with PBS only. Six days
later, thymocytes were prepared, counted,
and analyzed by flow cytometry for expres-
sion of CD4 and CD8. The figure shows dot
blots from a representative experiment in
which two mice of each genotype have been
treated with 145±2C11. RAG2/2 or RAG2/2 3
pTa2/2 mice injected with PBS only had no
DP thymocytes (data not shown) as untreated
RAG2/2 controls.The absolute number of thy-
mocytes after anti-CD3e treatment is given
on top of each blot. Untreated or PBS-treated
RAG2/2 or RAG2/2 3 pTa2/2 mice had 1±3 3
106 thymocytes. An untreated pTa2/2 lit-
termate used as a control had 7 3 106 thymo-
cytes.Equivalent results were obtained in two
additional experiments.
the transition from the CD251442 to the CD252442 de- the expense of their immediate CD251442 precursors.
This finding is in line with the notion that activated lckvelopmental stage within the CD4282 double-negative
population is severely impaired, which results in an ac- mimics the function of the pre-TCR: whereas in normal
mice, only those CD251 cells are allowed to progresscumulation of CD251442 cells and an almost empty
CD252442 compartment (Figure 3). The few CD252442 to the CD252442 stage that can form a pre-TCR due to
productive TCRb rearrangement (Dudley et al., 1994),cells that remain in pTa2/2 mice are of small size (data
not shown) and therefore most likely noncycling, expression of an activated lck transgene triggers this de-
velopmental program essentially in all CD251 pre-T cells.whereas in normal mice, most CD252442 DN thymo-
cytes are large blasts (Penit et al., 1995), which rapidly Taken together, these results clearly demonstrate that
the function of activated lck does not depend on thedivide due to pre-TCR-mediated signals, that were re-
ceived at the preceding CD251 stage (Hoffman et al., presence of pTa, neither for triggering the efficient gen-
eration of DP thymocytes via their natural CD2524421996). Examination of CD25 and CD44 expression on
gated DN thymocytes from lck-transgenic, pTa2/2 mice precursors nor for inhibiting TCRb rearrangements. In-
terestingly, introduction of the activated lck transgenereveals that expression of activated lck restores the
generation of CD252442 cells (Figure 3, bottom left), into pTa WT mice resulted consistently in an even
greater increase in the total number of thymocytes thanwhich are now predominantly of large size (data not
shown). In fact, the transition from the CD251442 to in pTa2/2 littermates, giving rise to cell numbers signifi-
cantly exceeding those found in nontransgenic WT lit-the CD252442 stage is drastically enhanced in lck-
transgenic mice compared toWT controls, as evidenced termates or B6 controls (Figure 2, and data not shown).
Although it is clear that pTa is not required for the func-by the strong down-regulation of CD25 and the marked
increase in the percentage of CD252442 thymocytes at tioning of activated lck, the latter observation suggests
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Figure 2. (Top): Efficient Generation of DP Thymocytes and Reconstitution of Thymic Cellularity in pTa2/2 Mice by Introduction of Transgenes
Encoding Constitutively Active p56lck Kinase (lck*). (Bottom): Inhibition of TCRb Expression on DP Thymocytes in Mice Carrying lck* Transgenes
Thymocytes of mice derived from an F2 intercross between the lck-transgenic line pLGF-2954 and pTa2/2 mice were counted; triple-stained
with antibodies specific for CD4, CD8, and TCRb; and analyzed by three-color flow cytometry. The absolute number of thymocytes is given
on top of each dot blot, the percentage of cells in each population within the respective quadrant. The levels of TCRb expression on DP
thymocytes were determined by gating electronically on CD4-PE/CD8-R613 double-positive thymocytes. For comparison, see Figure 5, which
shows the pattern of TCRb expression on DP thymocytes from a normal (pTa1/1, nontransgenic) mouse. The results shown here are representa-
tive of four independent experiments.
that its presence has an enhancing influence on the copy number transgenic line was established and then
backcrossed onto pTa2/2 mice, generating F2 animalseffect of lck-derived signals and is not completely irrel-
evant. that expressed the tailless transgenes in the absence
or presence of endogeneous pTa.
Expression of tailless pTa-encoding transgenes inA Transgenic pTa Chain Lacking Its Cytoplasmic
Portion Corrects the Developmental Defects pTa-deficient mice resulted in a strong increase in abso-
lute thymocyte numbers, which was also visible macro-Associated with pTa Deficiency
In contrast toall conventional TCR(and immunoglobulin) scopically, as the thymi of transgenic pTa2/2 mice were
significantly larger than pTa-deficient thymi lacking themolecules, which have only a few residues at their car-
boxy-terminus extending into the cytoplasm, pTa is en- transgenes. The average number of thymocytes ob-
tained from tailless transgenics on the pTa2/2 back-dowed with an authentic cytoplasmic tail, which in the
mouse consists of z30 amino acids, including motifs ground was 66.4 3 106 (n 5 9), which is equivalent to
the number of thymocytes (67.4 3 106; n 5 8) foundthat could serve as phosphorylation sites for protein
kinase C and as docking sites for molecules with SH3- in tailless transgenics on a pTa1 control background
(Figure 4). The fact that this corresponds to only littledomains (Saint-Ruf et al., 1994). This has led to specula-
tion that the cytoplasmic portion of pTa may actively more than 50% of the number found in nontransgenic
pTa1 littermates or B6 control mice suggests that theparticipate in signal transduction.To test this hypothesis
experimentally, we constructed a tailless form of pTa, transgenes in general have a mild inhibitory effect on
thymocyte development.lacking its 29 carboxy-terminal residues (for details see
Experimental Procedures). Tailless pTa cDNA was Cytofluorometric analysis of thymocytes from trans-
genic and nontransgenic pTa2/2 littermates revealedcloned into the p1017 transgene expression cassette,
which contains the transcriptional control elements of that expression of tailless pTa could effectively reverse
the phenotype associated with pTa deficiency. Alongthe lck proximal promoter (Chaffin et al., 1990). A high
Rescue of Early T Cell Development in pTa2/2 Mice
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Figure 3. Comparison of Triple-Negative
Thymocyte Subsets as Defined by the Ex-
pression of CD25 and CD44 from B6 WT Mice
(Top), pTa-Deficient Mice (Middle), and
pTa2/2 Animals with Transgenes, Encoding
Either a Constitutively Active Form of p56lck
Kinase (Bottom Left) or Tailless pTa (Bottom
Right)
Thymocytes from three mice of the same ge-
notype were pooled and depleted for CD41
and CD81 cells with anti-CD4 and anti-CD8
antibodies and rabbit complement (see Ex-
perimental Procedures). Surviving thymo-
cytes were purified by Ficoll density centrifu-
gation and stained with a mix containing the
following antibodies: CD3-FITC, CD4-FITC,
CD8-FITC, CD19-FITC, GR1-FITC, MAC1-
FITC, CD25-Biotin, and CD442PE. CD25-
positive cells were labeled in a second step
with Streptavidin-TRICOLOR. Immature, tri-
ple-negative thymocytes were analyzed for
CD25 and CD44 expression by gating elec-
tronically on FITC-negative/low cells. The
data presented in the left and right panels,
respectively, were obtained in separate ex-
periments.
with the increase in total cell number, the percentage This finding indicates that a tailless pTa reinstates the
preferential expansion and maturation of those CD251of DP thymocytes was normalized in pTa2/2 tailless
transgenics, and the percentage of DN thymocytes, DN thymocytes that express a functional TCRb chain
and thus can reestablish the process of ªb selection.ºwhich is anomalously high in pTa knockout mice, was
strongly reduced (Figure 5, left panels). The restoration of early T cell development in tailless
transgenic pTa2/2 mice should also be visible in the DNAnalysis of TCRb expression on DP thymocytes in
normal mice reveals a characteristic pattern with ap- thymocyte population, as one would expect to see a
relief of the severe developmental block that occurs atproximately 50%±60% of DP thymocytes expressing in-
termediate levels of TCRb. This population is always the CD251442/low developmental stage in nontransgenic
pTa-deficient mice. Figure 3 shows the result of a CD25/significantly reduced in pTa2/2 mice (Figure 5, middle
panels) because many DP thymocytes that develop in CD44-specific staining of CD4/CD8-complement-
depleted DN thymocytes that were gated for the ab-a pTa2/2 background lack a functional TCRb chain (Buer
et al., 1997), reflecting the fact that these cells develop sence of CD4-, CD8-, CD3-, CD19-, GR1- and MAC1-
expressing cells. Whereas in pTa2/2 mice, .90% ofin the absence of pre-TCR-mediated ªb selection.º Most
interestingly, the percentage of DP thymocytes with in- gated DN thymocytes accumulate in the CD251442/low
compartment and only a few noncycling thymocytes aretermediate levels of TCRb cell surface expression was
fully restored to WT levels in pTa-deficient mice ex- found at the CD252442 stage, introduction of tailless
pTa transgenes results in strong down-regulation ofpressing tailless transgenes (Figure 5, middle panels).
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The Effect of Tailless pTa Expression
on the Development of gd Thymocytes
In sharp contrast to the development of ab T cells, the
generation of gd lineage cells is not impaired in pTa-
deficient mice. In fact, the absolute number of gd thymo-
cytes is consistently severalfold higher in pTa2/2 mice
compared to littermate controls (Fehling et al., 1995a)
(see also Table 1), which could be due to a relief of a
potential inhibitory influence of pTa and the pre-TCR on
gd development. In this context, it was of interest to
assess the influence of tailless pTa expression on the
generation of gd thymocytes. To this end, we performed
a three-color staining of thymocytes from a litter of eight
transgenic mice, including pTa1 and pTa2/2 animals,
with antibodies specific for CD4, CD8, and the gdTCR.
An age-matched B6 mouse and two nontransgenic pTa-
deficient mice were used as controls. We then deter-
mined the number of gd-expressing thymocytes in each
of the four developmental subpopulations that are de-
fined by the differential expression of CD4 and CD8
coreceptors.
In B6 and tailless transgenic mice, both the CD81
single-positive and the CD4181 double-positive com-
partments did not contain any TCRgdhigh thymocytes,
whereas in the CD81 population of pTa2/2 mice, a small
number of such cells could be detected (data not
Figure 4. Total Number of Thymocytes in pTa2/2 and pTa1 Mice in shown). As expected, in all mice, most gd cells were
the Presence or Absence of Transgenes Encoding a Tailless Form found in the CD4282 compartment. The top panels in
of pTa
Figure 6 show TCRgd histograms of DN thymocytes from
The table in the upper part of the figure gives the number of thymo- one representative mouse of each genotype. As re-cytes in individual animals of each genotype. These numbers are
ported previously, the DN compartment of pTa2/2 micedepicted below graphically in a scatter graph, with each open circle
is particularly rich in gd-expressing cells comprisingrepresenting a data point from a mouse.
30% of this subpopulation, whereas in WT mice, ,10%
of CD4282 cells are TCRgd1. The introduction of a
tailless pTa transgene into pTa2/2 mice results in a 30%±CD25, formation of a largepopulation of CD252442 cells,
50% decrease in the proportion of gd-expressing cells,and concomitant reduction in the population size of the
although their ratio and total number (Table 1) is clearlypreceding CD251442/low subset. Down-regulation of
not reduced to WT levels. However, and most interest-CD25 is in fact enhanced in pTa2/2 mice carrying tailless
ingly, there is no obvious difference in the percentagetransgenes in comparison with a B6 control. On the
and absolute number of TCRgd1 cells in the DN compart-other hand, cells in the reconstituted CD252442/low com-
ment of pTa-tailless transgenic mice, irrespective ofpartment express slightly higher levels of CD44 than
whether they are pTa1 or pTa2/2, which implies thatthose in the corresponding subset of a WT control. The
expression of tailless pTa actually augments the per-
reason for this disparity is currently unknown.
centage of CD4282 gd cells in mice that have maintained
Analysis of TCRb surface expression on CD4282 dou-
endogeneous pTa (Table 1, and Figure 6, top panels).
ble-negative thymocytes revealedan interesting expres-
A similar, though somewhat less pronounced effect
sion pattern in tailless pTa transgenic mice that was not is seen in the CD41 single-positive subpopulation. Anal-
found on the corresponding subset in control animals. ysis of many pTa2/2 mice has revealed consistently that
DN thymocytes in both pTa1 and pTa2/2 mice carrying a considerable fraction of CD41 thymocytes in such
tailless transgenes contain a discrete population of animals express high levels of a gdTCR (our unpublished
cells, constituting about one third of the total DN subset, data and Figure 6, bottom). This is of particular interest
which have intermediate levels of TCRb expression (Fig- since, to our knowledge, such a population has never
ure 5, left panels). In contrast, DN thymocytes in non- been described in normal mice (see also Figure 6, bot-
transgenic pTa2/2 mice are mostly negative or very low tom left). Introduction of transgenes encoding tailless
for TCRb expression, most likely because they cannot pTa into pTa-deficient mice leads to a significant reduc-
form a pre-TCR complex. Also, DN thymocytes of WT tion in the proportion of these cells (Figure 6, bottom),
mice do not contain a discrete population of cells with although the absolute number of CD41,TCRgd1 thymo-
intermediate TCRb expression levels. The appearance cytes seems to be unaffected (Table 1). Similar to the
of a substantial number of such cells in both pTa1 and observations made with respect to the DN compart-
pTa2/2 mice carrying tailless pTa transgenes suggests ment, expression of tailless pTa transgenes in a pTa1
that pTa assists in controlling the level of pre-TCR cell background results in the appearance of a CD41gd1
population, which is clearly not present in nontransgenicsurface expression.
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Figure 5. Flow Cytometric Analysis of Thymocytes from Transgenic Mice Expressing a Tailless Form of pTa (Tailless-TG) in the Presence
(pTa1) or Absence (pTa2/2) of Endogeneous pTa
A WT and a nontransgenic pTa knockout mouse (pTa2/2) are included as controls. (Left panels): CD4/CD8 profiles of total thymocytes. (Middle
panels): TCRb expression on gated DP (CD4181) thymocytes. (Right panels): TCRb expression on gated DN (CD4282) thymocytes. Markers
were set according to TCRb expression levels (low, intermediate, and high) on the total thymocyte population of the WT mouse.
pTa1 controls. Again, the absolute number of these cells the blockage of early T cell development normally asso-
ciated with pTa deficiency. Our findings have a numberis not different in pTa1 and pTa2/2 tailless transgenics
(Table 1). Although we present here only data from one of implications regarding the role of pTa in early thymo-
poiesis.particular experiment, similar stainings with a smaller
number of experimental animals have been performed
on separate occasions and have provided equivalent Efficient Generation of DP Thymocytes
through CD3e-Specific Antibodyresults. Taken together, our findings clearly indicate that
expression of a tailless pTa transgene under the control Treatment in the Absence of pTa
Previous experiments have shown that treatment of fetalof the lck proximal promoter has a marked and partly
opposing influence on the generation of gd thymocytes, thymic organ cultures derived from SCID, RAG-, or
TCRb-deficient mice with anti-CD3e antibodies (Leveltboth in pTa-deficient and in pTa WT mice.
et al., 1993) or injection of such antibodies into RAG-
deficient mice (Shinkai and Alt, 1994; Jacobs et al., 1994)Discussion
can trigger efficient expansion and maturation of DN
thymocytes and thus restore early T cell developmentMice lacking the pre-TCRa (pTa) chain due to targeted
gene disruption exhibit a severedefect in ab T cell devel- in these mouse mutants. Here, we have tested whether
in vivo administration of CD3e-specific antibodies canopment that is characterized by impaired expansion and
differentiation of CD251442 DN thymocytes, a drastic also overcome the severe developmental block ob-
served in pTa2/2 mice. To avoid the toxic effects ofreduction in the number of DP thymocytes, and a con-
comitant decrease in total thymic cellularity (Fehling et anti-CD3 antibodies on thymocyte development in the
presence of mature T cells, we first introduced the pTaal., 1995a). Here, we demonstrate that three distinct
experimental manipulations, namely, intraperitoneal in- mutation on a RAG2/2 background. A single intraperito-
neal injection of the anti-CD3e-specific antibody 2C11jection of anti-CD3e antibodies, introduction of trans-
genes encoding activated lck, and expression of pTa into RAG2/2 (pTa1) mice and RAG2/2 3 pTa2/2 double-
deficient littermates resulted in a strong induction of DPchains lacking their cytoplasmic residues, can surpass
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cells and the generation of essentially normal numbers
of thymocytes in both types of animals, indicating that
pTa was not required for anti-CD3e-induced expansion
and maturation.
In mature T cells, CD3 subunits are expressed on the
cell surface only in association with clonotypic chains
of the TCR complex. Expression of signaling-competent
CD3 components on the cell surface of immature thymo-
cytes, which lack mature TCR chains, has been puzzling
since itwas first described (Levelt et al., 1993). Recently,
strong evidence has been provided that clonotype-inde-
pendent CD3 complexes can reach the cell surface in
association with calnexin, an integral membrane protein
previously thought to reside only in the endoplasmic
reticulum (Wiest et al., 1995). However, this observation
does not exclude that functional (signaling-competent)
cell surface expression of CD3 components may actu-
ally depend on thepresence of pre-T cell±specific recep-
tor chains, which need not be rearranged, and can
substitute for conventional TCR chains in immature thy-
mocytes. The identification and characterization of pTa
as a nonrearranging pre-T cell±specific gene has been
in line with such a hypothesis. However, here, we show
that anti-CD3e treatment can overcome the develop-
mental defect associated with pTa deficiency, which
implies that pTa is neither required for cell surface ex-
pression of CD3e on immature thymocytes nor for effi-
cient signal transduction after anti-CD3e antibody treat-
ment. These findings argue against a role of pTa in
TCRb-independent functions and make the existance
of a hypothetical surrogate TCRb chain obsolete.
Functioning of Activated p56lck
in the Absence of pTa
A role for the nonreceptor tyrosine kinase p56lck in T
cell signaling was originaly identified in more mature
thymocytes and T cells by virtue of its physical associa-
tion with the TCR coreceptors CD4 and CD8 (Glaichen-
haus et al., 1991; reviewed by Veillette et al., 1991). Only
later, it was noticed that p56lck also plays an important
role in early thymocyte development and is critically
involved in the transduction of pre-TCR-mediated sig-
nals (reviewed by Anderson and Perlmutter, 1995). For
instance, in mice with a targeted disruption of the lck
gene, maturation of ab thymocytes is severely impaired
at the same developmental stage as in mouse mutants,
which fail to generate a functional pre-TCR complex
(Molina etal., 1992). This is also true for mice that overex-
press dominant-negative lck (Levin et al., 1993). More-
over, transgenes encoding a catalytically activated form
of p56lck restore the development of DP thymocytes in
RAG2/2 mice (Mombaerts et al., 1994). Taken together,
current experimental evidence suggests a model of pre-
TCR signaling in which formation of a pre-TCR or inter-
action of the pre-TCR with specific ligands leads to
the activation of associated p56lck kinase, which in turn
phosphorylates tyrosine residues within the ITAM motifs
of CD3 components (reviewed by Anderson and Perl-
mutter, 1995). This scenario implies that p56lck must in-
teract directly with the pre-TCR complex or at least be
brought in its proximity, even after it has been activated,
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in order tophosphorylate CD3 chains. However, specific
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Figure 6. gd TCR Expression on DN (CD4282) and CD41 Single-Positive (CD4182) Thymocytes from a WT and a Nontransgenic pTa Knockout
Mouse (pTa2/2), and Transgenic Mice Expressing a Tailless Form of pTa (Tailless-TG) in the Presence (pTa1) or Absence (pTa2/2) of Endoge-
neous pTa
Markers were set according to TCRgd expression levels (low, high) on CD4282 thymocytes from the pTa2/2 mouse.
binding sites for lck within the pre-TCR have not yet effect of activated lck transgenes on T cell development
in CD3-deficient mice, which, similar to RAG2/2 animals,been identified, and CD4 or CD8 coreceptors, which
seem to fulfill such a function inmore mature thymocytes exhibit a complete arrest of thymopoiesis at the
CD251442 stage (Malissen et al., 1995) but can no longerand T cells, are not available at this early developmental
stage. Since pTa constitutes a core element of the pre- provide CD3e or CD3g chains that could serve as sub-
strates or attachment sites for p56 lck.TCR complex, we decided to assess the functioning of
activated lck in the absence of pTa. Interestingly, expression of activated lck in a pTa1
background resulted consistently in an even more pro-Our analysis has clearly shown that transgenes en-
coding activated lck can fully restore the development nounced increase in the number of thymocytes than in
pTa2/2 mice, suggesting that pTa, though not neces-of DP thymocytes in pTa-deficient mice. These data
complement previous findings in lck-transgenic RAG2/2 sary, can enhance lck activity. This finding may have a
rather trivial explanation, for instance, the presence ofmice (Mombaerts et al., 1994) and provide independent
evidence that lck plays a central role in pre-TCR signal pTa may simply increase the number of CD3 complexes
on the cell surface, which would provide additional lcktransduction.
Our data also demonstrate that pTa is not required targets for binding and/or phosphorylation. On the other
hand, the fact that pTa is not absolutely required for lckfor the proper functioning of activated lck, clearly ex-
cluding an obligatory role for pTa in recruiting the acti- function does not automatically rule out a positive effect
on the recruitment of lck into the pre-TCR complex.vated kinase into the pre-TCR complex. This conclusion
agrees with our finding that anti-CD3e-induced expan-
sion and maturation are also efficient in the absence of
pTa, which would not be possible if a pTa±lck interaction Effect of Tailless pTa Transgenes on Early
T Cell Developmentwas required, taking into account that anti-CD3e-medi-
ated effects are largely lck dependent (Levelt et al., The mouse pTa polypeptide is an invariant transmem-
brane protein that consists of a single immunoglobulin-1995). Since activated lck needs neither pTa (this study)
nor TCRb (Mombaerts et al., 1994) to perform its func- like extracellular domain, a transmembrane region, and
a carboxy-terminal cytoplasmic region of z30 aminotion, it most likely interacts with the cytosolic portions
of CD3 chains, at least some of which are thought to acids (Saint-Ruf et al., 1994). The identification of an
authentic cytoplasmic tail in pTa came as a surprise inserve as enzymatic substrates of lck. However, it cannot
be excluded that lck, once it has been activated, does that all other known TCR and immunoglobulin molecules
are devoid of such a structure. The fact that this cyto-not need to stably interact with pre-TCR components
any longer and that it mediates its effects on early T cell plasmic tail was found to contain potential serine±
threonine phosphorylation sites for protein kinase C anddevelopment by phosphorylating other, perhaps intra-
cellular targets. The observed phosphorylation of cer- motifs that could serve as docking sites for molecules
with SH3 domains suggested initially that it may be di-tain CD3components could then be merely coincidental.
In this context, it would be interesting to analyze the rectly involved in the transduction of pre-TCR-mediated
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signals (Saint-Ruf et al., 1994). However, cloning of hu- pTaÐhas revealed a population of cells with intermedi-
ate expression levels of TCRb that is not apparent inman pTa and comparison with its mouse homolog re-
vealed that the cytoplasmic tails in these species did nontransgenic mice. We see two obvious explanations
for this phenomenon. First, the number of WT pTa chainsnot share any sequence similarities, although all other
parts of both molecules were highly homologous (Del may be limiting for the cell surface expression of pre-
TCR complexes, and provision of additional transgenicPorto et al., 1995). This finding argued against an impor-
tant function of the cytoplasmic tail, but it could not (tailless) pTa chains may therefore lead to a proportional
increase in pre-TCR formation. The low steady-statebe excluded that functionally equivalent motifs in both
molecules are difficult to reveal by simple sequence levels of pTa mRNA in normal DN thymocytes seems to
argue in favor of this hypothesis (our unpublished data).alignment. To resolve this issue and to assess experi-
mentally the importance of the cytoplasmic residues of Second and probably less likely, the cytoplasmic tail of
pTa might contain an as yet uncharacterized endoplas-mouse pTa, we generated transgenic mice expressing
tailless pTa under the control of the lck proximal pro- mic reticulum retention motif, and the replacement of
WT pTa by a tailless form would lead to higher levelsmoter, which were then crossed with pTa-deficient
mice. of pre-TCR cell surface expression. Both explanations
are based on theassumption that the intermediate levelsThe analysis of these animals revealed that tailless
pTa chains efficiently restore ab T cell development in of TCRb on DN thymocytes reflect pre-TCR expression
and not low level expression of a mature ab TCR on apTa knockout mice: the severe blockage in the transition
from CD251442 to CD252442 thymocytes was over- novel TCRab DN subpopulation. The latter possibility
could be formally ruled out by introducing the taillesscome, the cellularity and proportion of the DP compart-
ment was reconstituted, and the preferential expansion transgene into mice that are deficient for TCRa. Such a
breeding is currently in progress.and maturation of thymocytes with functional TCRb re-
arrangements (ªb selectionº) was reinstated. All in all, Finally, the effect of pTa and its tailless form on gd
T cell development merits special comment. Previoustailless pTa chains normalized the proportion of thymic
subsets, as defined by CD4 and CD8 expression, and analyses of pTa2/2 mice have demonstrated unequivo-
cally that the development of gd T cells does not dependincreased the total number of thymocytes to levels simi-
lar to those found in tailless transgenics with a pTa1 on the presence of pTa. On the contrary, both the pro-
portion and absolute number of gd-expressing thymo-background.
However, we must point out that these results do not cytes are significantly elevated in pTa-deficient mice,
perhaps because of a direct negative influence of pTaimply that there is absolutely no role for the cytoplasmic
tail in pre-TCR function. We have to bear in mind that and the pre-TCR on gd T cell development. Here, we
show that a pTa-deficient thymus not only harbors aour transgene is expressed at significantly higher levels
than endogeneous pTa, at least at the level of mRNA larger number of gd cells, but it also features a novel
population of gd-expressing cells that coexpress CD4.(z50-fold more message as determined by Northern
blotting [data not shown]). It therefore cannot be ex- Such a population cannot be detected in normal mice
and, to our knowledge, has not been reported pre-cluded that a possibly larger number of pTa molecules
per cell may mask subtle effects of the cytoplasmic tail viously. Although we do not have any data regarding the
functional properties of these cells, the peculiar surfaceand override a potential contribution to the functioning
of pTa. In particular, we cannot rule out a minor, quanti- phenotype suggests that the absence of pTa affects gd
T celldevelopment not only quantitatively but can lead totative contribution of the cytoplasmic residues of pTa
to pre-TCR activity, but we clearly demonstrate that the a qualitatively different thymic subpopulationÐa finding
that may hint at a direct role of pTa in gd lineage deci-cytoplasmic tail of mouse pTa is not indispensible for
pre-TCR function. sions.
Although introduction of tailless pTa chains in pTa2/2The observation that the overall number of thymo-
cytes in mice carrying tailless pTa transgenes is reduced mice reduces the percentage and absolute number of
gd-expressing cells in the DN compartment, a somewhatby approximately 40%±50% compared to nontrans-
genic controls, even in pTa1 animals, could be inter- higher proportion of gd-expressing cells than in WT con-
trols is maintained. Most surprising, the number of gdpreted as a specific though very mild dominant-negative
effect, suggesting that pre-TCR complexes containing thymocytes actually increases in pTa1 mice upon intro-
duction of a tailless transgene. This suggests that thetailless pTa chains are slightly less efficient in mediating
thymocyte expansion than those with WT pTa. On the rise in the number of gd cells in pTa2/2 on one hand and
tailless transgenic mice on the other, relative to WTother hand, the observed negative effect may merely
reflect a disturbance in the finely tuned process of thy- controls, are brought about by different mechanisms.
For instance, one could envisage a scenario in whichmocyte development, brought about by the overexpres-
sion of transgenes at an early developmental stage and pTa is expressed only in cells that are destined to follow
the ab pathway, inhibiting directly or indirectly the drift-in an expression pattern that does not fully mimic the
physiologic pattern. In line with this interpretation, an ing of these cells into the gd lineage, which would occur
in the absence of pTa in those cells that manage tooverall reduction in thymocyte number is not an uncom-
mon phenomenon in mice carrying thymocyte-specific rearrange both TCRg and TCRd loci productively. In con-
trast, tailless transgenic pTa under the control of thetransgenes (our unpublished data).
The analysis of TCRb expression on the cell surface proximal lck promoter may be expressed aberrantly also
in cells that are committed to the gd lineage. It may thenof DN thymocytes in tailless pTa transgenic miceÐ
irrespective of their genotype regarding endogeneous pair with TCRb, if present, or more provocatively with
Rescue of Early T Cell Development in pTa2/2 Mice
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(53±6.7; GIBCO, MD); FITC anti-mouse CD11b (Mac1a) (M1/70,TCRg and lead to expansion of these cells, which nor-
Pharmingen); FITC anti-mouse CD19 (1D3, Pharmingen, CA); Biotinmally do not express a pre-TCR or pre-TCR-like com-
anti-mouse CD25 (7D4, Pharmingen, CA); R-PE anti-mouse CD44plex. This interpretation would predict the existance of
(IM7, Pharmingen, CA); FITC anti-mouse TCRb (H57±597, Phar-
two separate precursor populations for ab and gd lin- mingen, CA); FITC anti-mouse gd TCR (GL3, Pharmingen, CA); FITC
eage cells that can be distinguished based on the pres- anti-mouse Ly-6G (GR1) (RB6±8C5, Pharmingen, CA); R-PE
anti-mouse CD45R/B220 (RA3±6B2, Pharmingen, CA); FITC sheepence or absence of pTa expression. This point is cur-
anti-mouse Ig F(ab')2 fragment (Silenus, Australia). Streptavidin con-rently under investigation.
jugates were: Streptavidin-TRICOLOR (Caltag, CA) and streptavidin-
APC (Molecular Probes, OR).Experimental Procedures
For flow cytometry, single cell thymocyte suspensions were pre-
pared in phosphate-buffered saline (PBS) containing 2% calf serum.Mice
Cell numbers were determined using a Coulter counter. ThymocytesC57BL/6 (B6) mice, which were used as WT controls in some experi-
were stained at 5 3 106 cells per ml in PBS±2% fetal calf serumments, were purchased from IFFA-Credo (France). All other mice
containing the relevant antibodies at saturating concentrations.were bred and maintained in the animal colony of the Basel Institute
Phenotypes and proportions of thymocyte subsets were analyzedfor Immunology. The genotype of mice with respect to endogeneous
by three-color flow cytometry using a FACScan (Beckton Dickinson)pTa and the tailless pTa transgene was determined by Southern
and the Lysis II program. Dead cells were excluded from the analysisblotting of EcoRV/BamHI-digested tail DNA using as a probe a geno-
by forward and side scatter gating.mic PstI/XhoI fragment (z610 bp) corresponding to positions 5432±
6046 of the pTa gene (numbering according to Fehling et al., 1995b).
Depletion of CD4- and CD8-Expressing ThymocytesThis probe combined with the EcoRV±BamHI digest allows both the
Single-cell suspensions from thymi of three individual mice with thedistinction between pTa1/1, 1/2, and 2/2 mice and at the same time
same genotype werepooled, resuspended in 8 ml serum-freeDMEMthe identification of tailless pTa transgenes due to distinctly sized
medium, and incubated simultaneously with 1 ml of anti-CD8bands.
(3.168.8.1) and 1 ml of anti-CD4 (RL172.4) antibody supernatantsThe lck-transgenic mice (line pLGF-2954) have been described
on ice for 30 min. The cells were then washed in 10 ml DMEM±2%in detail elsewhere (Abraham et al., 1991). The lck transgene was
calf serum and resuspended in 9 ml of the same medium. Afteridentified by dot blot hybridization of tail DNA using as a probe a
adding 1 ml of freshly dissolved rabbit complement (Low-Tox-M,PstI±EcoRI fragment (z625 bp) from the 39 untranslated region of
Cedarlane), the suspension was incubated at 378C for40 min.Surviv-the human growth hormone gene, which is part of the transgenic
ing cells were purified by Ficoll density±gradient centrifugation,construct (Abraham et al., 1991).
washed, and resuspended in PBS±2% calf serum. The efficiency ofBreeding stocks of RAG-2-deficient mice have been kindly pro-
CD4±CD8 depletion was usually .99% as determined by stainingvided by Dr. F. Alt (Boston). RAG-22/2 animals were identified based
purified thymocytes with R-PE anti-mouse CD4 (H129.19) and R613on the absence of B2201/surface Ig1 B lymphocytes as evidenced
anti-mouse CD8a (53±6.7) antibodies, which bind epitopes distinctby double staining of peripheral blood cells with B220-PE and sheep
from those recognized by antibodies 3.168.8.1 and RL172.4.anti-mouse Ig-FITC antibodies.
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